Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The different face of skin-rash induced by brentuximab vedotin.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

Sponge-like sonographic pattern of the spleen in immune dysregulation disorders.

Frontiers in immunology·2026
Same author

Lymphoproliferation in inborn errors of immunity: From challenging diagnosis to histologic revision.

Journal of human immunity·2026
Same author

B-cell and plasma cell proliferations associated with T follicular helper cell lymphomas: clinical-pathological and genetic features.

Virchows Archiv : an international journal of pathology·2026
Same author

Modern and multidisciplinary care in polycythemia vera.

Annals of hematology·2026
Same author

Mediastinal grey zone lymphomas: Results of the expert pathological review analysis of a case series enrolled in the multicentre BIOGZL-2020 study in Italy.

British journal of haematology·2026

Related Experiment Video

Updated: May 20, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

BCL10 down-regulation in peripheral T-cell lymphomas.

Maura Rossi1, Claudio Agostinelli, Simona Righi

  • 1Molecular Pathology Laboratory, Hematopathology Section, Department of Hematology and Oncological Sciences L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Italy.

Human Pathology
|July 24, 2012
PubMed
Summary

BCL10 gene expression is commonly reduced in peripheral T cell lymphomas (PTCLs). This downregulation suggests further investigation into the T-cell receptor signaling pathway in PTCL pathogenesis.

More Related Videos

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Related Experiment Videos

Last Updated: May 20, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • The BCL10 gene is crucial for T-cell receptor signaling and nuclear factor κB (NFκB) activation.
  • BCL10 expression is documented in normal lymphoid tissues and B-non Hodgkin lymphomas, with aberrant function implicated in pathogenesis.
  • Existing data on BCL10 expression in peripheral T cell lymphomas (PTCLs) are conflicting.

Purpose of the Study:

  • To analyze BCL10 expression in PTCLs.
  • To correlate BCL10 expression with NFκB activation, proliferation, phenotypic aberration, and patient survival.
  • To investigate the role of BCL10 in PTCL pathogenesis.

Main Methods:

  • Gene expression analysis of 40 PTCLs, 4 reactive lymph nodes, and 20 normal T-lymphocyte samples.
  • Immunohistochemical analysis of BCL10 expression in 52 PTCLs using tissue microarrays.
  • Correlation analysis with Ki-67, T-cell markers, NFκB activation, gene expression profiles, progression-free survival, and overall survival.

Main Results:

  • Significantly lower BCL10 gene expression was observed in all PTCL subtypes compared to normal T-lymphocytes, with the lowest levels in anaplastic large cell lymphoma.
  • BCL10 protein expression was detected in 19% (10/52) of PTCLs, with no significant correlation to proliferation markers, NFκB activation, or distinct gene expression profiles.
  • No significant correlation was found between BCL10 expression and progression-free or overall survival, though a trend towards a favorable outcome was noted in BCL10-positive cases.

Conclusions:

  • BCL10 is frequently downregulated in peripheral T cell lymphomas.
  • The findings suggest a potential role for the T-cell receptor signaling cascade in PTCL characterization.
  • Further research is warranted to elucidate the precise role of BCL10 in PTCL pathogenesis.